1.Clinical application of meglucamine diatrizoate mucilage in 500 cases of bronchography
Liubin CHEN ; Shuigen GONG ; Qiang WANG
Journal of Third Military Medical University 2001;23(3):367-368
Objective To evaluate the effects of meglumine diatrizoate mucilage (MDC) used as contrast medium in bronchography. Methods A total of 500 patients undergoing bronchography were reviewed, including male 346, female 154, with an average age of 42 (ranged 5~71). Among them, 415 were examined with bilateral bronchography in a dose of 20~30 ml, 85 with unilateral bronchography in 10~15 ml of MDC. Results In 487 cases (97.4%), the lobes, segments, subsegment bronchi were revealed very well, and 456 cases (91.2%) had no cough. Conclusion MDC is regarded as an ideal bronchial contrast medium, and may replace dionosil and iodized oil.
2.Effect of the modification of ste aric acid solid lipid nanoparticles by chemical coating with Brij 78 on their body distribution in mice
Dabing CHEN ; Jie WANG ; Qiang ZHANG
Journal of Peking University(Health Sciences) 2001;33(3):233-237
Objective: To investigate the effect of s urface modification of stearic acid solid lipid nanoparticles with Brij 78 on the body distribution. Me thods: T he stearic acid solid lipid nanoparticles were prepared by “emulsi on-evaperation-solidfied at low temperature" method with two kinds of surfacta nts: Brij 78 and taurocholic acid sodium salt. Groups of five randomly selected Kun Ming mice of both sexes were used for each suspension and for each time point. After injection of each suspension into the tail vein, one group of mice were killed a t e ach time point. Then the blood, liver, spleen, lung, heart, kidney, muscles and fat were removed and the dpm value of 100 μl blood and 50 mg of each tissue was determined. Results: Compared with the nanoparticles taurocholi c acid sodium salt, the AUC (tissue)/AUC(blood) value of to spleen, lung, heart and kidney with the nanoparticles modified with Brij 78 was increased to 1 12.5%, 143.6%, 146.7% and 184.8% respectively. Conclusion: The distribution of stearic acid solid l ipid nanoparticles into the non-RES organs can be increased and the circulating time may be prolonged by modifying the nanoparticle surface with Brij 78.
4.Posterior single segment fusion or non-fusion in treatment of lumbar spinal disease:a comparative study
Zhaohui CHEN ; Qiang FU ; Cong WANG
Orthopedic Journal of China 2006;0(08):-
[Objective]To compare the treatment effects between posterior single segment fusion or non-fusion in lumbar spinal disease,and to evaluate their influence on adjacent segments.[Method]Thirty-two cases of degenerative lumbar spinal disorders were treated with Coflex(group non-fusion) and PLIF(group fusion),and followed up for over 2 years.The clinical effect was evaluated by visual analogue scale(VAS) and Oswestry disability index(ODI).Range of motion(ROM) of lumbar segments was measured by X-ray film.[Result]In group non-fusion,VAS decreased from 7.8?1.2 pre-operatively to 2.1?0.6 at final follow-up,ODI from 30.8?3.2 to 4.6?1.2,ROM improved significantly.In group fusion,VAS decreased from 7.2?1.1 to 2.0?0.6,ODI from 29.9?3.0 to 4.5?0.9,and ROM of L3、4 improved significantly.No significant difference of clinical effect was found between 2 groups.[Conclusion]Both fusion and non-fusion fixation have satisfying effects in treatment of degenerative lumbar spinal disorder.Non-fusion fixation has less influence on ROM of lumbar segments and could reduce adjacent segment degeneration.
5.Treatment of intrasacrospinal muscular approach and midline approach in lumbar interbody fixation with fusion for lumbar spinal stenosis
Qiang WANG ; Jing YANG ; Lijuan CHEN
Clinical Medicine of China 2016;32(5):459-462
Objective To explore the clinical effect about the treatment of intrasacrospinal muscular approach and midline approach in lumbar interbody fixation with fusion for lumbar spinal stenosis.Methods Forty-two cases lumbar spinal stenosis were reviewed retrospectively in Meitan General Hospital from February 2009 to February 2014.All cases were divided into intrasacrospinal muscular approach and midline approach group(Group A,n =19) and midline approach group(Group B,n =23) according to the different surgical approach.Operation time,the amount of blood loss,post-operative drainage were compared.The VAS score of low back pain and leg pain preoperative and 6 months after operation were recorded.All cases were followed up for more than one year to evaluate fusion status.Results All cases were followed up for 13.0-20.0 months,with an average of (16.0± 1.2) months,all patients had bony fusion.Operation time,the amount of blood loss,postoperative drainage of Group A were significantly less than of Group B,the differences were significant ((95.1±4.5) min vs.(110.4±6.6) min,(75.2±5.1) ml vs.(159.8±7.2) ml,(53.6±4.3) ml vs.(86.2±14.1) ml;t =1.565,6.087,2.371;P<0.05).VAS of back pain and leg pain at 6 months after operation of Group A showed better results than of Group B,the differences were significant((1.43±0.76) points vs.(1.39±1.00) points,(2.78± 1.23) points vs.(2.52±0.88) points;t =1.982,1.774;P<0.05).Interbody fusion was obtained in two groups at the end of the last follow-up.Conclusion The intrasacrospinal muscular approach and midline approach for lumbar interbody fixation with fusion for lumbar spinal stenosis is better in less injury to paraspinal muscle,less blood loss and less post-operative drainage,which contributes a rapid recovery.
7.Efficacy in the Treatment of Senile Patients with Bronchopneumonia and Effects on Immune Function of Pidotimod
Qiang WANG ; Xinmin ZHU ; Peifeng CHEN
China Pharmacist 2015;(3):431-433
Objective:To investigate the efficacy of pidotimod in the treatment of elderly patients with bronchial pneumonia and its effect on immune function. Methods: Totally 85 cases of elderly patients with bronchial pneumonia were randomly divided into two groups:the pidotimod treatment group (43 cases) and the conventional therapy group (42 cases). The conventional therapy group was given moxifloxacin 400 mg·d-1 , ivd, the pidotimod treatment group was additionally with pidotimod oral solutions 800 mg,po,bid, and the treatment course was 10 days. The changes of immune function in the two groups were detected, and the symptoms including fever, cough, asthma, rale and lung spots in X-ray radiation and the symptom duration in the two groups were also compared. Results:After the treatment, the levels of CD4, CD4 / CD8 and NK cells in the two groups were significantly higher than those before the treat-ment, the level of CD8 cells and IgA, IgG, IgM expression levels were significantly lower than those before the treatment (P<0. 05), and the changes in the pidotimod treatment group were much notable than those in the conventional therapy group(P<0. 05). The in-cidence of fever, cough, asthma, rale and lung spots in X-ray radiation in the pidotimod treatment group was lower than that in the con-ventional therapy group(P<0. 01), and the symptom duration was shorter than that in the conventional therapy group(P<0. 01). Conclusion:The mechanisms of pidotimod in the effective treatment of bronchial pneumonia in elderly patients are relative to the im-provement of T cell subsets, NK cells and humoral immunity levels and the enhancement of immunity.
8.The protective and therapeutic effect of tetramethylpyrazine against spinal cord ischemic injury in rabbits
Qiang WANG ; Lize XIONG ; Shaoyang CHEN
Chinese Journal of Anesthesiology 1994;0(03):-
Objective To investigate the effect of tetramethylpyrazine(TMP), a traditional Chinese herbal medicine, on the neural injury caused by spinal cord ischemia and reperfusion in rabbit.Methods Twenty-two male New Zealand white rabbits were anesthetized with isoflurane. Spinal cord ischemia was induced by 20min by infra-renal aortic occlusion. Animals were randomly allocated to 3 groups. Group C received no pharmacologic intervention. Group P and T received 30 mg?kg -1 TMP infused iv at a constant rate over 30min before aortic crossclamping(prevention) and after reperfusion(therapeutic) respectively. Neurologic deficit was assessed at 4, 8, 12, 24 and 48h after reperfusion using neurologic dificit score(NDS 4 = normal, 0 = paraplegia) . The animals were sacrificed at 48h after reperfusion and spinal cords (L 5-7) were removed immediately for histopathologic study.Results All animals survived the experiment. The NDSs at each observation interval were significantly higher in group P and T than those in group C (P
9.The causes and management of postsplenectomy fever in patients with portal hypertension
Xiongwei ZHU ; Gangliang CHEN ; Qiang WANG ; Zhiqian HU ; Xueyun CHEN ;
Chinese Journal of General Surgery 1993;0(02):-
Objective To investigate the cause and management of postsplenectomy fever in portal hypertensive patients . Methods The clinical data of 295 portal hypertension patients undergoing splenectomy from 1990 to 2003 were reviewed. Among these,80 patients suffered from a continuous fever higher than 38.5℃ for more than 2 weeks postoperatively. Results Except for two patients with unknown cause, 78 of 295 patients with continuous fever were caused by complications such as splenoportal thrombosis(35 cases), infection of hematocele or hydrops in splenic recess(20 cases), left subphrenic infection(7 cases), pneumonia and hydrothorax or empyema(5 cases), 3 cases each of postoperative abscess of tail of pancreas,winary tract infection and inteclion of surgical incision, 1 case of leakage of esophageal anastomosis and intraabdominal infection in 1 case. The lasting fever was related to the grade of liver function(P0.05). Conclusions Splenoportal thrombosis, and hematocele, hydrops or infection in the splenic recess were the main causes of persistent fever after splenectomy. Prevention and treatment of infection and amelioration of hepatic function will help to reduce the rate of postoperative continuous fever.